---
title: "Outbrain to report EPS of $-0.05 on May 9, with investors hoping for positive guidance. Past misses led to share price drops. Shares trading at $3.37, down 22.44% in the last 52 weeks. Analyst opinions crucial for investor decisions."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239405408.md"
description: "Outbrain (NASDAQ: OB) will report its quarterly earnings on May 9, 2025, with an expected EPS of $-0.05. Investors are looking for positive guidance after past misses led to share price declines. Currently, shares are trading at $3.37, down 22.44% over the last year. Analyst opinions are crucial for investor decisions, as previous earnings misses have resulted in significant price drops."
datetime: "2025-05-08T17:28:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239405408.md)
  - [en](https://longbridge.com/en/news/239405408.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239405408.md)
---

# Outbrain to report EPS of $-0.05 on May 9, with investors hoping for positive guidance. Past misses led to share price drops. Shares trading at $3.37, down 22.44% in the last 52 weeks. Analyst opinions crucial for investor decisions.

Outbrain (NASDAQ: OB) is set to announce its quarterly earnings report on May 9, 2025, with analysts predicting an earnings per share (EPS) of $-0.05. Investors are eager for Outbrain to exceed expectations and provide positive guidance for the next quarter, understanding that market reactions often hinge on this guidance rather than just earnings performance. In the previous quarter, Outbrain missed EPS estimates by $0.04, leading to a 5.8% drop in share price the next day. Outbrain's earnings history shows fluctuating performance, with price changes ranging from -6.0% to -1.0% based on meeting or missing estimates. Currently, Outbrain shares are trading at $3.37, down by 22.44% over the past 52 weeks. Analysts’ opinions on Outbrain are pivotal for investor decision-making and can be found in more detail on Benzinga.com.

### Related Stocks

- [OB.US](https://longbridge.com/en/quote/OB.US.md)

## Related News & Research

- [Stocks in Play: WildBrain Ltd.](https://longbridge.com/en/news/282053118.md)